Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Preserving preclinical PET quality during intratherapeutic imaging in radionuclide therapy with Rose metal shielding reducing photon flux.

Mellhammar EM, Dahlbom M, Evans-Axelsson S, Strand SE.

J Nucl Med. 2018 Nov 2. pii: jnumed.118.217117. doi: 10.2967/jnumed.118.217117. [Epub ahead of print]

PMID:
30389819
2.

A good beginning with an uncertain future.

Schelbert HR, Dahlbom M.

J Nucl Cardiol. 2017 Oct 30. doi: 10.1007/s12350-017-1091-9. [Epub ahead of print] No abstract available.

PMID:
29086387
3.

Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline.

Torosyan N, Mason K, Dahlbom M, Silverman DHS; Alzheimer’sDisease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1355-1363. doi: 10.1007/s00259-017-3634-3. Epub 2017 Mar 22.

PMID:
28331953
4.

Pancreatic Fat Is Associated With Metabolic Syndrome and Visceral Fat but Not Beta-Cell Function or Body Mass Index in Pediatric Obesity.

Staaf J, Labmayr V, Paulmichl K, Manell H, Cen J, Ciba I, Dahlbom M, Roomp K, Anderwald CH, Meissnitzer M, Schneider R, Forslund A, Widhalm K, Bergquist J, Ahlström H, Bergsten P, Weghuber D, Kullberg J.

Pancreas. 2017 Mar;46(3):358-365. doi: 10.1097/MPA.0000000000000771.

5.

A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images.

Forgacs A, Pall Jonsson H, Dahlbom M, Daver F, D DiFranco M, Opposits G, K Krizsan A, Garai I, Czernin J, Varga J, Tron L, Balkay L.

PLoS One. 2016 Oct 13;11(10):e0164113. doi: 10.1371/journal.pone.0164113. eCollection 2016.

6.

Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy.

Mellhammar E, Dahlbom M, Axelsson J, Strand SE.

J Nucl Med. 2016 Dec;57(12):1964-1970. Epub 2016 Jul 28.

7.

A Promising Future: Comparable Imaging Capability of MRI-Compatible Silicon Photomultiplier and Conventional Photosensor Preclinical PET Systems.

Krizsan AK, Lajtos I, Dahlbom M, Daver F, Emri M, Kis SA, Opposits G, Pohubi L, Potari N, Hegyesi G, Kalinka G, Gal J, Imrek J, Nagy F, Valastyan I, Kiraly B, Molnar J, Sanfilippo D, Balkay L.

J Nucl Med. 2015 Dec;56(12):1948-53. doi: 10.2967/jnumed.115.157677. Epub 2015 Oct 8.

8.

Characterization of a double-sided silicon strip detector autoradiography system.

Örbom A, Ahlstedt J, Serén T, Auterinen I, Kotiluoto P, Hauge H, Östlund K, Olafsen T, Wu AM, Dahlbom M, Strand SE.

Med Phys. 2015 Feb;42(2):575-84. doi: 10.1118/1.4905049.

PMID:
25652478
9.

Validation of the SimSET simulation package for modeling the Siemens Biograph mCT PET scanner.

Poon JK, Dahlbom ML, Casey ME, Qi J, Cherry SR, Badawi RD.

Phys Med Biol. 2015 Feb 7;60(3):N35-45. doi: 10.1088/0031-9155/60/3/N35. Epub 2015 Jan 14.

PMID:
25586800
10.

Assessing margin expansions of internal target volumes in 3D and 4D PET: a phantom study.

Jani SS, Lamb JM, White BM, Dahlbom M, Robinson CG, Low DA.

Ann Nucl Med. 2015 Jan;29(1):100-9. doi: 10.1007/s12149-014-0914-x. Epub 2014 Oct 8.

PMID:
25292484
11.

Automated movement correction for dynamic PET/CT images: evaluation with phantom and patient data.

Ye H, Wong KP, Wardak M, Dahlbom M, Kepe V, Barrio JR, Nelson LD, Small GW, Huang SC.

PLoS One. 2014 Aug 11;9(8):e103745. doi: 10.1371/journal.pone.0103745. eCollection 2014.

12.

Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET.

Packard RR, Huang SC, Dahlbom M, Czernin J, Maddahi J.

J Nucl Med. 2014 Sep;55(9):1438-44. doi: 10.2967/jnumed.114.141093. Epub 2014 Jul 28.

13.

Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom.

Lajtos I, Czernin J, Dahlbom M, Daver F, Emri M, Farshchi-Heydari S, Forgacs A, Hoh CK, Joszai I, Krizsan AK, Lantos J, Major P, Molnar J, Opposits G, Tron L, Vera DR, Balkay L.

Phys Med Biol. 2014 Jun 7;59(11):2727-46. doi: 10.1088/0031-9155/59/11/2727. Epub 2014 May 6.

PMID:
24800813
14.

¹⁸F-FLT    and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.

Wardak M, Schiepers C, Cloughesy TF, Dahlbom M, Phelps ME, Huang SC.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1199-209. doi: 10.1007/s00259-013-2678-2. Epub 2014 Mar 7.

15.

MAP reconstruction for Fourier rebinned TOF-PET data.

Bai B, Lin Y, Zhu W, Ren R, Li Q, Dahlbom M, DiFilippo F, Leahy RM.

Phys Med Biol. 2014 Feb 21;59(4):925-49. doi: 10.1088/0031-9155/59/4/925. Epub 2014 Feb 7.

16.

Uppsala Longitudinal Study of Childhood Obesity: protocol description.

Forslund A, Staaf J, Kullberg J, Ciba I, Dahlbom M, Bergsten P.

Pediatrics. 2014 Feb;133(2):e386-93. doi: 10.1542/peds.2013-2143. Epub 2014 Jan 13.

17.

A comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion.

Jani SS, Robinson CG, Dahlbom M, White BM, Thomas DH, Gaudio S, Low DA, Lamb JM.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):562-9. doi: 10.1016/j.ijrobp.2013.06.2042.

18.

Evaluation of the Genisys4, a bench-top preclinical PET scanner.

Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, Czernin J.

J Nucl Med. 2013 Jul;54(7):1162-7. doi: 10.2967/jnumed.112.114926. Epub 2013 Apr 29.

19.

Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy.

Zhang X, Schindler TH, Prior JO, Sayre J, Dahlbom M, Huang SC, Schelbert HR.

Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):532-41. doi: 10.1007/s00259-012-2311-9. Epub 2013 Jan 4.

20.

Dynamic PET/CT with 11C-acetate in prostate cancer.

Schiepers C, Huang SC, Dahlbom M.

J Nucl Med. 2013 Feb;54(2):326. doi: 10.2967/jnumed.112.112532. Epub 2012 Dec 21. No abstract available.

21.

Optimal whole-body PET scanner configurations for different volumes of LSO scintillator: a simulation study.

Poon JK, Dahlbom ML, Moses WW, Balakrishnan K, Wang W, Cherry SR, Badawi RD.

Phys Med Biol. 2012 Jul 7;57(13):4077-94. doi: 10.1088/0031-9155/57/13/4077. Epub 2012 Jun 7.

22.

WE-G-213CD-02: 4D-PET Maximum Intensity Projections Improve Accuracy of Mobile Tumor Volume Delineation.

Jani S, Lamb J, Dahlbom M, Robinson C, White B, Low D.

Med Phys. 2012 Jun;39(6Part28):3970-3971. doi: 10.1118/1.4736203.

PMID:
28519634
23.

SU-E-J-169: 4D-PET for Abdominal Tumor Target Volume Generation.

Lamb J, Lee P, Jani S, Dahlbom M, White B, Low D.

Med Phys. 2012 Jun;39(6Part8):3691. doi: 10.1118/1.4735008.

PMID:
28518934
24.

TU-E-218-01: PET/CT QA/QC and Acceptance Testing.

Dahlbom M, Mawlawi O.

Med Phys. 2012 Jun;39(6Part24):3916-3917. doi: 10.1118/1.4735985.

PMID:
28518678
25.

SU-E-I-82: Image Signal-To-Noise Equalization in Whole Body PET Using Variable Acquisition Times.

Dahlbom M, Kriszan A, Czernin J.

Med Phys. 2012 Jun;39(6Part5):3644. doi: 10.1118/1.4734799.

PMID:
28517659
26.

Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations.

Wong KP, Kepe V, Dahlbom M, Satyamurthy N, Small GW, Barrio JR, Huang SC.

Neuroimage. 2012 Mar;60(1):241-51. doi: 10.1016/j.neuroimage.2011.12.014. Epub 2011 Dec 16.

27.

3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.

Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Geist C, Dahlbom M, Silverman DH, Satyamurthy N, Phelps ME, Chen W.

J Nucl Med. 2012 Jan;53(1):29-36. doi: 10.2967/jnumed.111.092387. Epub 2011 Dec 12.

28.

Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma.

Wardak M, Schiepers C, Dahlbom M, Cloughesy T, Chen W, Satyamurthy N, Czernin J, Phelps ME, Huang SC.

Clin Cancer Res. 2011 Oct 15;17(20):6553-62. doi: 10.1158/1078-0432.CCR-10-3290. Epub 2011 Aug 25.

29.

Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest.

Maddahi J, Czernin J, Lazewatsky J, Huang SC, Dahlbom M, Schelbert H, Sparks R, Ehlgen A, Crane P, Zhu Q, Devine M, Phelps M.

J Nucl Med. 2011 Sep;52(9):1490-8. doi: 10.2967/jnumed.111.092528. Epub 2011 Aug 17.

30.

Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning.

Groman SM, Lee B, London ED, Mandelkern MA, James AS, Feiler K, Rivera R, Dahlbom M, Sossi V, Vandervoort E, Jentsch JD.

J Neurosci. 2011 May 18;31(20):7291-9. doi: 10.1523/JNEUROSCI.0363-11.2011.

31.

Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.

Schiepers C, Dahlbom M.

Eur Radiol. 2011 Mar;21(3):548-54. doi: 10.1007/s00330-010-2033-y. Epub 2010 Dec 21.

32.

Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma.

Schiepers C, Dahlbom M, Chen W, Cloughesy T, Czernin J, Phelps ME, Huang SC.

J Nucl Med. 2010 May;51(5):720-7. doi: 10.2967/jnumed.109.068361. Epub 2010 Apr 15.

33.

Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.

Wardak M, Wong KP, Shao W, Dahlbom M, Kepe V, Satyamurthy N, Small GW, Barrio JR, Huang SC.

J Nucl Med. 2010 Feb;51(2):210-8. doi: 10.2967/jnumed.109.063701. Epub 2010 Jan 15.

34.

Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.

Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA.

J Neurosci. 2009 Nov 25;29(47):14734-40. doi: 10.1523/JNEUROSCI.3765-09.2009.

35.

Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.

Wong KP, Wardak M, Shao W, Dahlbom M, Kepe V, Liu J, Satyamurthy N, Small GW, Barrio JR, Huang SC.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):575-88. doi: 10.1007/s00259-009-1293-8. Epub 2009 Oct 31.

36.

Seroprevalence of canine herpesvirus-1 and Brucella canis in Finnish breeding kennels with and without reproductive problems.

Dahlbom M, Johnsson M, Myllys V, Taponen J, Andersson M.

Reprod Domest Anim. 2009 Feb;44(1):128-31. doi: 10.1111/j.1439-0531.2007.01008.x. Epub 2008 Sep 10.

PMID:
18992103
37.

Radiation dose to surgical staff from positron-emitter-based localization and radiosurgery of tumors.

Heckathorne E, Dimock C, Dahlbom M.

Health Phys. 2008 Aug;95(2):220-6. doi: 10.1097/01.HP.0000310962.96089.44.

PMID:
18617803
38.

1-11C-acetate kinetics of prostate cancer.

Schiepers C, Hoh CK, Nuyts J, Seltzer M, Wu C, Huang SC, Dahlbom M.

J Nucl Med. 2008 Feb;49(2):206-15. doi: 10.2967/jnumed.107.044453. Epub 2008 Jan 16.

39.

Covalent interlinking of an aldehyde and an amine on a Au(111) surface in ultrahigh vacuum.

Weigelt S, Busse C, Bombis C, Knudsen MM, Gothelf KV, Strunskus T, Wöll C, Dahlbom M, Hammer B, Laegsgaard E, Besenbacher F, Linderoth TR.

Angew Chem Int Ed Engl. 2007;46(48):9227-30. No abstract available.

PMID:
17968866
40.

18F-FDOPA kinetics in brain tumors.

Schiepers C, Chen W, Cloughesy T, Dahlbom M, Huang SC.

J Nucl Med. 2007 Oct;48(10):1651-61. Epub 2007 Sep 14.

41.

Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction.

Schindler TH, Zhang XL, Vincenti G, Mhiri L, Nkoulou R, Just H, Ratib O, Mach F, Dahlbom M, Schelbert HR.

J Nucl Cardiol. 2007 Sep-Oct;14(5):688-97.

42.

Assignment of the Qy absorption spectrum of photosystem-I from Thermosynechococcus elongatus based on CAM-B3LYP calculations at the PW91-optimized protein structure.

Yin S, Dahlbom MG, Canfield PJ, Hush NS, Kobayashi R, Reimers JR.

J Phys Chem B. 2007 Aug 23;111(33):9923-30. Epub 2007 Aug 2.

PMID:
17672486
43.

Pressure-induced spectral changes for the special-pair radical cation of the bacterial photosynthetic reaction center.

Leiger K, Freiberg A, Dahlbom MG, Hush NS, Reimers JR.

J Chem Phys. 2007 Jun 7;126(21):215102.

PMID:
17567219
44.
45.

Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET.

Schindler TH, Zhang XL, Prior JO, Cadenas J, Dahlbom M, Sayre J, Schelbert HR.

Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1178-88. Epub 2007 Mar 3.

PMID:
17334762
46.

18F-fluorothymidine kinetics of malignant brain tumors.

Schiepers C, Chen W, Dahlbom M, Cloughesy T, Hoh CK, Huang SC.

Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1003-11. Epub 2007 Feb 13.

PMID:
17295039
47.

Accuracy of PET/CT in characterization of solitary pulmonary lesions.

Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, Czernin J, Schiepers C.

J Nucl Med. 2007 Feb;48(2):214-20.

48.

Charge delocalization in the special-pair radical cation of mutant reaction centers of Rhodobacter sphaeroides from Stark spectra and nonadiabatic spectral simulations.

Kanchanawong P, Dahlbom MG, Treynor TP, Reimers JR, Hush NS, Boxer SG.

J Phys Chem B. 2006 Sep 21;110(37):18688-702.

PMID:
16970500
49.

Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans.

Prior JO, Schindler TH, Facta AD, Hernandez-Pampaloni M, Campisi R, Dahlbom M, Schelbert HR.

Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):20-7. Epub 2006 Aug 11.

PMID:
16902794
50.

Semiautomated analysis of small-animal PET data.

Kesner AL, Dahlbom M, Huang SC, Hsueh WA, Pio BS, Czernin J, Kreissl M, Wu HM, Silverman DH.

J Nucl Med. 2006 Jul;47(7):1181-6.

Supplemental Content

Loading ...
Support Center